4,4'-Methylenedimorpholine

Suppliers

Names

[ CAS No. ]:
5625-90-1

[ Name ]:
4,4'-Methylenedimorpholine

[Synonym ]:
4-(morpholin-4-ylmethyl)morpholine
Morpholine, 4,4'-methylenebis-
4,4'-Methylenedimorpholine
EINECS 227-062-3
4,4'-methanediyldimorpholine
MFCD00593814

Chemical & Physical Properties

[ Density]:
1.1±0.1 g/cm3

[ Boiling Point ]:
265.1±35.0 °C at 760 mmHg

[ Molecular Formula ]:
C9H18N2O2

[ Molecular Weight ]:
186.251

[ Flash Point ]:
77.6±23.2 °C

[ Exact Mass ]:
186.136826

[ PSA ]:
24.94000

[ LogP ]:
-0.06

[ Vapour Pressure ]:
0.0±0.5 mmHg at 25°C

[ Index of Refraction ]:
1.497

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
QE6125000
CHEMICAL NAME :
Morpholine, 4,4'-methylenedi-
CAS REGISTRY NUMBER :
5625-90-1
BEILSTEIN REFERENCE NO. :
0111886
LAST UPDATED :
199712
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C9-H18-N2-O2
MOLECULAR WEIGHT :
186.29
WISWESSER LINE NOTATION :
T6N DOTJ A1- AT6N DOTJ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1 gm/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
ZEKBAI Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. Volume(issue)/page/year: 71,105,1968 ** TUMORIGENIC DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
50 mg/kg
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Tumorigenic - tumors at site of application
REFERENCE :
FCTXAV Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. Volume(issue)/page/year: 6,576,1968
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
2000 mg/kg/40W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Peripheral Nerve and Sensation - peripheral nerve tumors Tumorigenic - tumors at site of application
REFERENCE :
ZEKBAI Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. Volume(issue)/page/year: 71,105,1968

Safety Information

[ Hazard Codes ]:
Xn: Harmful;Xi: Irritant;

[ Risk Phrases ]:
R20/21/22;R36/37/38

[ Safety Phrases ]:
26-36/37/39

Synthetic Route

Precursor & DownStream

Precursor

  • morpholine
  • Formaldehyde
  • Dichloromethane
  • Bis(dimethylamino)methane
  • 4-methylenemorpholin-4-ium chloride
  • 3-ethyl-3-methyloxaziridine
  • 5,5',6,6',7,7',8,8'-Octahydro-1,1'-bi-2-naphthol
  • N-Trimethylsilylmorpholine
  • trimethyl(morpholin-4-ylmethoxy)silane
  • 4-(dimorpholin-4-ylmethyl)morpholine

DownStream

  • 4-Nitrosomorpholine
  • Cyclotrimethylenetrinitramine
  • 4-Phenylmorpholine
  • morpholine,nitric acid
  • 4-((DIPHENYLPHOSPHORYL)METHYL)MORPHOLINE
  • morpholine
  • 4-Morpholinylmethanol
  • 4-[(5-bromopyridin-2-yl)Methyl]morpholine
  • N-CHLOROMORPHOLINE
  • N-CHLOROMETHYLMORPHOLINE

Related Compounds

  • 4,4'-methylenebis[2,6-dicyclopentylphenol]
  • 4,4'-carbonimidoylbis[N,N-diethylaniline]
  • 4,4'-(1-methylpentylidene)bisphenol
  • 4,4'-dimethylselenobenzophenone
  • 4,4'-(3,3-bis(4-bromophenyl)prop-1-ene-1,1-diyl)bis(ethoxybenzene)
  • 4,4'-Oxydibenzenesulfonohydrazide
  • cyclooct-2-yn-1-yl (4-nitrophenyl) carbonate
  • (2,2-dimethoxy-1-methyl-ethyl) 4-methylbenzenesulfonate
  • tert-butyl 4-[6-[(E)-2-(dimethylamino)vinyl]-5-nitro-2-pyridyl]piperazine-1-carboxylate
  • 2-Nitro-4-(oxetan-3-yloxy)aniline
  • N-(2-nitro-4-(oxetan-3-yloxy)phenyl)formamide
  • 1-(4-Carboxyphenyl)-1H-pyrazole-4-carboxylic acid
  • 2,1-Benzoxaborole-6-ethanamine, 1,3-dihydro-1-hydroxy-3,3-dimethyl-
  • 1-((tetrahydro-2H-pyran-3-yl)methyl)-1H-pyrazole
  • 2-(5-cyclopropyl-1H-pyrazol-3-yl)isoindoline-1,3-dione
  • 1-benzhydryl-4-bromo-1H-pyrazole
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.